Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in Mice-Reference-Cited by-同舟云学术

Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in Mice

Published:2022-02 Issue:7 Volume:79 Page:632-647
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Sun Yanyi,Pinto Cristina,Camus Stéphane,Duval Vincent,Alayrac Paul,Zlatanova Ivana,Loyer Xavier,Vilar Jose,Lemitre Mathilde,Levoye Angélique,Nus Meritxell,Ait-Oufella Hafid,Mallat Ziad,Silvestre Jean-Sébastien

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. The inflammatory response in myocardial injury, repair, and remodelling;Frangogiannis;Nat Rev Cardiol,2014

2. Innate lymphoid cells promote recovery of ventricular function after myocardial infarction;Yu;J Am Coll Cardiol,2021

3. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction;Zouggari;Nat Med,2013

4. Immunosuppression with FTY720 reverses cardiac dysfunction in hypomorphic ApoE mice deficient in SR-BI expression that survive myocardial infarction caused by coronary atherosclerosis;Luk;J Cardiovasc Pharmacol,2016

5. Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury;Adamo;JCI Insight,2018

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Avenues to Modulate B-Cell Function in Patients With Cardiovascular Disease;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-07

2. The roles of B cells in cardiovascular diseases;Molecular Immunology;2024-07

3. The roles of Th cells in myocardial infarction;Cell Death Discovery;2024-06-15

4. B cell-mediated antigen presentation promotes adverse cardiac remodeling in chronic heart failure;2024-05-11

5. IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction;Inflammopharmacology;2024-04-27